Does pain relief during delivery decrease the risk of postnatal depression?
Pauliina Hiltunen, Tytti Raudaskoski, Hanna Ebeling, Irma Moilanen, Pauliina Hiltunen, Tytti Raudaskoski, Hanna Ebeling, Irma Moilanen
Abstract
Background: To test the hypothesis that sufficient pain relief during delivery decreases the risk of postnatal depression.
Methods: As part of a prospective follow-up study of the risk factors for postnatal depression and its impact on the mother-infant interaction and child development, 185 parturients filled in the Edinburgh Postnatal Depression Scale (EPDS), first during the first postpartum week and again (n = 162) 4 months later. The incidence and the risk of high EPDS scores was calculated according to the mode of delivery and the mode of pain relief during vaginal delivery, also after adjusting for the length of labor.
Results: Mothers who received epidural/paracervical blockade during their delivery spent less time in the delivery room than mothers in the nitrous oxide/acupuncture group (p = 0.033) or mothers with no pain relief (p = 0.026) and had shorter length of labor than mothers without pain relief (p = 0.04). The adjusted risk of depressive scores at the first postnatal week was decreased in the epidural/paracervical group when compared with no analgesia group (OR: 0.25, 95% CI: 0.09-0.72). This difference was not shown at 4 months postpartum. Elective or emergency cesarean section did not increase the risk of high EPDS scores at the first week or at 4 months postpartum.
Conclusion: The mode of pain relief during vaginal delivery seems to be associated with the incidence of postpartum depression, especially immediately after delivery.
Source: PubMed
Tulevat kliiniset tutkimukset
-
Assiut UniversityEi vielä rekrytointia
-
Beijing Tiantan HospitalEi vielä rekrytointiaAkuutti iskeeminen aivohalvaus | Suuri suonen tukosKiina
-
Cumhuriyet UniversityEi vielä rekrytointiaLeikkauksen jälkeinen kipu, akuutti | Modifioitu radikaali mastektomia | KasvotasolohkotTurkki (Türkiye)
-
Mayo ClinicRoche Pharma AG; Advanced Research Projects Agency for HealthEi vielä rekrytointia
-
The First Affiliated Hospital of Soochow UniversityRekrytointiAcute Myeloid LeukemaKiina
-
IRCCS San RaffaeleAzienda Ospedaliero-Universitaria Maggiore della Carità di Novara; Ospedale... ja muut yhteistyökumppanitEi vielä rekrytointia
-
Lisa SatterAbbVie; National Center for Advancing Translational Sciences (NCATS)Ei vielä rekrytointiaJAK1 GOF | STAT1 GOF | STAT3 GOF | STAT5B GOF | STAT6 GOFYhdysvallat
-
Sichuan Academy of Medical SciencesRekrytointiNeuronal Intranuclear Inclusion Disease (NIID)Kiina
-
Tianjin Medical University Cancer Institute and...Ei vielä rekrytointiaPatients With Low HER2 Expression (IHC 1+ or IHC 2+/ISH-) and HER2 IHC 0 Advanced Breast Cancer
-
Akiva CohenEi vielä rekrytointiaAivotärähdys | Aivotärähdys, aivot | MTBI - lievä traumaattinen aivovaurio | Aivotärähdys (diagnoosi)
-
Izmir Bakircay UniversityRekrytointiChemotherapy-Related Taste AlterationTurkki (Türkiye)
-
Centre Mohammed VI de la Recherche et de l'Innovation...RekrytointiVuorovaikutus huumeruoka | Syöpä (kiinteät kasvaimet)Marokko